Annual General Meeting approves agenda with a clear majority
Executive Board and Supervisory Board have been discharged
Outlook for the 2013 fiscal year confirmed
Berlin, Germany, August 7, 2013 - MagForce AG (Frankfurt, Entry Standard, XETRA: MF6), a leading medical device company in the field of nanomedicine focused on oncology, held its annual general meeting yesterday, August 6, 2013, in Berlin. The annual general meeting approved all of the items on the agenda with a clear majority and granted discharge to the Executive and Supervisory Boards for the 2012 fiscal year. The Executive Board members Prof. Dr. Hoda Tawfik and Christian von Volkmann provided a status update regarding current operational developments, an overview of the 2012 fiscal year and the outlook for the current year. The Executive and Supervisory Boards were pleased with the outcome of the resolutions.
The Executive Board`s presentation is available from the company`s website at http://www.magforce.de/presse-investoren/hauptversammlung (German only).
About MagForce AG
MagForce AG is a leading medical device company in the field of nanomedicine in oncology. The Company`s proprietary, NanoTherm therapy, enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles. NanoTherm, NanoPlan, and NanoActivator(TM) are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm, NanoPlan, and NanoActivator(TM) are trademarks of MagForce AG in selected countries. For more information, please visit http://www.magforce.com.
Disclaimer
This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects", "aims", "anticipates", "intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-looking statements are based on our current expectations and certain assumptions, which may be subject to a variety of risks and uncertainties. The results actually achieved by MagForce AG may substantially differ from these forward-looking statements. MagForce AG assumes no obligation to update these forward-looking statements or to correct them in case of developments, which differ from those, anticipated.
The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Visit link:
Annual General Meeting of MagForce AG